These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 8511923)

  • 21. [A case report: modified PMUE therapy might be effective for advanced gastric carcinoma with pulmonary carcinomatous lymphangitis].
    Oyama K; Fushida S; Taniguchi K; Bando E; Fujita H; Michiwa Y; Fujimura T; Nishimura G; Yonemura Y; Miwa K
    Gan To Kagaku Ryoho; 1999 Apr; 26(5):691-5. PubMed ID: 10234302
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Scirrhous cancer of the stomach which survived for more than five years after neoadjuvant chemotherapy with UFT (uracil and tegafur) and cisplatin.
    Maeda O; Iwase H; Mamiya N; Nakamura M; Mizuno T; Nishio Y; Ando T; Ina K; Kusugami K
    Intern Med; 2000 Mar; 39(3):239-44. PubMed ID: 10772128
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Long-term follow-up of a pilot phase II study with neoadjuvant epidoxorubicin, etoposide and cisplatin in gastric cancer.
    Barone C; Cassano A; Pozzo C; D'Ugo D; Schinzari G; Persiani R; Basso M; Brunetti IM; Longo R; Picciocchi A
    Oncology; 2004; 67(1):48-53. PubMed ID: 15459495
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Randomized study with mitomycin C + 5-fluorouracil+cytosine arabinoside (MFC)+5-fluorouracil, MFC+tegafur and uracil (UFT), and MF+UFT in advanced gastric cancer: interinstitutional differences in a multicenter study in Japan.
    Furukawa H; Iwanaga T; Nakajima T; Okabayashi K; Nakazato H; Hiratsuka M; Ohta K; Kito T; Yamamura Y; Goto S
    J Surg Oncol; 1995 Sep; 60(1):59-64. PubMed ID: 7666668
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [A case of advanced gastric carcinoma with disappearance of cancer cells by neoadjuvant chemotherapy].
    Nakagawachi T; Yunotani S; Nakamura M; Samejima R; Shida T; Yonemitsu N; Eguchi T; Miyazaki K
    Gan To Kagaku Ryoho; 1998 Oct; 25(12):1955-8. PubMed ID: 9797819
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Advanced gastric cancer curatively resected following combined neoadjuvant chemotherapy--report of a case].
    Koike N; Ohwada S; Ogawa T; Kawashima K; Takeyoshi I; Sato Y; Kamiyama H; Morishita Y
    Gan To Kagaku Ryoho; 1998 May; 25(6):919-23. PubMed ID: 9617332
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Neoadjuvant chemotherapy in scirrhous cancer of the stomach using uracil and tegafur and cisplatin.
    Suga S; Iwase H; Shimada M; Nishio Y; Ichihara T; Ichihara S; Kusugami K; Saito H
    Intern Med; 1996 Dec; 35(12):930-6. PubMed ID: 9030989
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [A resected case of stage IV gastric cancer successfully treated with TS-1/CDDP as neoadjuvant chemotherapy].
    Oshiro Y; Moon Y; Yamamoto Y; Aita K
    Gan To Kagaku Ryoho; 2006 May; 33(5):667-70. PubMed ID: 16685169
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Posttherapy nodal status, not graded histologic response, predicts survival after neoadjuvant chemotherapy for advanced gastric cancer.
    Fujitani K; Mano M; Hirao M; Kodama Y; Tsujinaka T
    Ann Surg Oncol; 2012 Jun; 19(6):1936-43. PubMed ID: 22187120
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Neoadjuvant chemotherapy of gastric cancer with oral UFT (a mixture of uracil and fturafur) during the waiting period for surgery.
    Nio Y; Sato Y; Nagami H; Teramoto M; Inoue Y; Yano S; Sumi S; Tamura K; Fukumoto M
    Anticancer Res; 1998; 18(1B):523-30. PubMed ID: 9568172
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Neoadjuvant chemotherapy using TS-1 and CDDP against large type 3/Type 4/Bulky N 2 advanced gastric cancer].
    Tanemura H; Oshita H; Kanno A; Kusakabe M; Hatoh T; Yamada M; Adachi T; Nishio K; Saito S; Tomita E; Sugiyama A; Yamada T
    Gan To Kagaku Ryoho; 2005 Dec; 32(13):2079-85. PubMed ID: 16352932
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [A case of stage IV advanced gastric cancer responding to TS-1/CDDP neoadjuvant chemotherapy which leads to a pathological complete response].
    Hiraoka K; Mizutani S; Oyama T; Uchikoshi F; Yoshidome K; Tori M; Ueshima S; Yamagami Y; Takahashi H; Nakahara M; Tsujimoto M
    Gan To Kagaku Ryoho; 2007 Jan; 34(1):93-5. PubMed ID: 17220679
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Postsurgical sequential methotrexate, fluorouracil, and leucovorin for stages 3 and 4 gastric carcinoma: A preliminary study.
    Tokunaga Y; Kitaoka A; Yagi T; Tokuka A; Ohsumi K
    J Surg Oncol; 2000 Sep; 75(1):31-6. PubMed ID: 11025459
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [A case of far-advanced gastric cancer treated with neoadjuvant combination chemotherapy of UFT, low-dose CDDP and leucovorin, followed by subtotal gastrectomy with curative intent].
    Yamamoto S; Hirata T; Yamagishi S; Yamashita Y; Hirano S; Kutsukata N; Masuda S; Hisayoshi T; Hioki M
    Gan To Kagaku Ryoho; 1997 Jul; 24(9):1157-60. PubMed ID: 9239171
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Preoperative and postoperative combination chemotherapy for potentially resectable gastric carcinoma.
    Ajani JA; Mayer RJ; Ota DM; Steele GD; Evans D; Roh M; Sugarbaker DJ; Dumas P; Gray C; Vena DA
    J Natl Cancer Inst; 1993 Nov; 85(22):1839-44. PubMed ID: 8230264
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [A case of advanced gastric cancer with multiple liver metastasis successfully treated with combination chemotherapy using UFT, CDDP and etoposide].
    Ono T; Komatsu M; Hoshino T; Ishii T; Fujii K; Ohshima S; Mikami K; Masamune O; Fukuda T
    Gan To Kagaku Ryoho; 1996 Oct; 23(12):1709-12. PubMed ID: 8886050
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [A resected case of advanced gastric cancer with complete remission of liver metastasis by chronic daily administration of oral etoposide and UFT].
    Mura T; Bandou H; Nomura T; Watanabe K; Kobayashi T
    Gan To Kagaku Ryoho; 1992 Jul; 19(7):1071-4. PubMed ID: 1626943
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antitumor effect and survival benefit of chemotherapy for unresectable advanced gastric cancer.
    Kiyohashi A; Kurihara M; Yoshida S; Ohkubo T; Suga S
    Jpn J Clin Oncol; 1993 Feb; 23(1):41-5. PubMed ID: 8459640
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Validity of neoadjuvant chemotherapy with docetaxel, cisplatin, and S-1 for resectable locally advanced gastric cancer.
    Sasaki K; Onodera S; Otsuka K; Satomura H; Kurayama E; Kubo T; Takahashi M; Ito J; Nakajima M; Yamaguchi S; Miyachi K; Kato H
    Med Oncol; 2017 Aug; 34(8):139. PubMed ID: 28707042
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Type-oriented intraoperative and adjuvant chemotherapy and survival after curative resection of advanced gastric cancer.
    Shimoyama S; Shimizu N; Kaminishi M
    World J Surg; 1999 Mar; 23(3):284-91; discussion 291-2. PubMed ID: 9933701
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.